Can you take a lower dose of Wegovy, and when does it make sense?

What the licensed schedule actually says about lower doses

The STEP 1 trial (68 weeks, semaglutide 2.4 mg versus placebo, published in the New England Journal of Medicine) showed around 15% average body-weight reduction at the full maintenance dose. That headline figure comes from participants who completed the full titration. What the trial design also reflected, and what the approved summary of product characteristics formalises, is a stepwise schedule built around tolerability: 0.25 mg for four weeks, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg.

None of those earlier steps are dummy stages. At each level, semaglutide is active. Weight loss at lower doses is real, even if the magnitude is smaller than at 2.4 mg. The titration exists because the gastrointestinal side-effect profile (nausea, reflux, altered bowel habits) tends to be most pronounced when the dose rises, and a slow ascent gives the body time to adapt. Staying at 1.0 mg for eight weeks instead of four is not a failure; it is the schedule doing its job.

NICE's appraisal of semaglutide (TA875) and the prescribing guidance both acknowledge that some patients reach a tolerated dose below the maximum. The clinical expectation is to titrate to the highest dose the patient tolerates, which leaves room for individual variation. If 1.7 mg is where your body settles, that is a clinical outcome, not a gap in treatment.

When a prescriber might reduce or hold your dose

A common misconception is that asking for a lower dose means giving up on results. That framing gets it backwards. The reason prescribers have the option to step back is that pushing through severe nausea or vomiting at pace can lead to dehydration, poor nutrition, and people stopping treatment altogether. A temporary reduction protects the treatment, not just the patient's comfort.

Dose reductions are most often considered in a few situations: side effects that are significantly affecting daily life and not settling after two weeks at the current level; a period of illness where GI symptoms are compounded; or, occasionally, a planned break around surgery. The NHS England guidance on weight management injections notes that healthcare teams should be informed before any surgical procedure, and that dose pauses may be appropriate in those circumstances.

What is not advised is reducing the dose unilaterally. The timing of reductions, how long to hold at a lower level, and when to attempt re-titration are clinical decisions. A prescriber can also weigh up whether a lower dose is likely to be sufficient for your specific health picture, which self-management cannot replicate. You can find more on how the full dose range is structured on our Wegovy doses page.

Lower doses, results, and the question of staying there long-term

People sometimes ask whether they could simply remain on a lower dose indefinitely (say, 1.0 mg) rather than titrating further. The honest answer is that this depends on clinical judgement and your individual response. Some patients achieve meaningful, sustained weight loss at sub-maintenance doses, particularly if lifestyle changes are running in parallel. Others plateau and need the higher dose to maintain progress. If you are considering what options exist at the earlier steps of the schedule, our page on Wegovy lower dose covers the practical and clinical picture in more detail.

The evidence base for Wegovy's weight-management licence is built around the 2.4 mg dose (and, more recently, the 7.2 mg single-dose pen approved by the MHRA in April 2026 for adults with a BMI of 30 or above). Long-term data at lower doses as a deliberate maintenance strategy is thinner. That does not make it wrong, it makes it a decision to take with your prescriber, armed with your actual weight trajectory and side-effect history, rather than an assumption either way. A question that comes up regularly is whether taking two doses of 0.25 mg Wegovy is ever appropriate, and the short answer is that this is not how the licensed schedule works, something our dedicated page explains in full.

If you are weighing up whether staying on a lower dose might suit your situation, our page on staying on a lower dose of Wegovy goes into more detail on the clinical considerations. And if you're curious how results tend to vary by dose level, the 0.5 mg weight loss results page covers what the data shows at that specific step.

For a broader look at how Wegovy compares to other licensed options, the treatment overview is a sensible next read. If you would like a prescriber to review your current dose or discuss starting treatment, you can start a free consultation with our team, a real clinician reads your answers the same day. Another common query we see is whether you can take two doses of Wegovy at once, for example if a dose is missed or delayed, and our page on that topic sets out what the guidance actually recommends.